NCATS DPI TDB INFUSE HEALTH EQUITY PRECLINICAL DEVELOPMENT

NIH RePORTER · NIH · N02 · $265,336 · view on reporter.nih.gov ↗

Abstract

The Health FFRDC Operator to provide independent, expert technical, analytical, and subject matter support to conduct a survey of the rare disease landscape, develop and identify best practices for infusing an equity perspective, and lay the groundwork for a pilot of preclinical and therapeutics research into rare diseases with health disparity implications. The Health FFRDC will provide the timely integration and application of many disciplines and functional specialties that are too broad and complex to acquire through individual, competitive procurements with commercial contractors.

Key facts

NIH application ID
11042042
Project number
75N95022F00142-P00005-0-1
Recipient
MITRE CORPORATION
Principal Investigator
PAULA HUSTON
Activity code
N02
Funding institute
NIH
Fiscal year
2024
Award amount
$265,336
Award type
Project period
2022-09-12 → 2024-09-14